CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells

CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells

Summary: The apoptosis inducing receptor CD95/Fas has multiple tumorigenic activities. In different genetically engineered mouse models tumor-expressed CD95 was shown to be critical for cell growth. Using a combination of immune-deficient and immune-competent mouse models, we now establish that loss...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdul S. Qadir, Jean Philippe Guégan, Christophe Ginestier, Assia Chaibi, Alban Bessede, Emmanuelle Charafe-Jauffret, Manon Macario, Vincent Lavoué, Thibault de la Motte Rouge, Calvin Law, Jacob Vilker, Hongbin Wang, Emily Stroup, Matthew J. Schipma, Bryan Bridgeman, Andrea E. Murmann, Zhe Ji, Patrick Legembre, Marcus E. Peter
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
Immunology
Cell biology
Cancer
Science
Q
Online Access:https://doaj.org/article/01c1b9341da244a5b4a9946be1c614bf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/01c1b9341da244a5b4a9946be1c614bf

Similar Items